Skip to main content

Pharmacotherapy of Emotion Dysregulation

Edited by:
Stefan Röpke, MD, Charité - Universitätsmedizin Berlin, Germany

Submission Status: Closed

This collection is no longer accepting submissions.


Borderline Personality Disorder and Emotion Dysregulation is calling for submissions to our Collection on Pharmacotherapy of Emotion Dysregulation.

Image credit: © stellalevi / Getty Images / iStock

  1. Frequently presenting with symptoms of mood or anxiety disorders, substance abuse or borderline personality disorder, suicidal and self-harming adolescents often are prescribed psychotropic medication. Though ...

    Authors: Lars Mehlum, Joan Asarnow, Sudan Prasad Neupane, Pilar Santamarina-Perez, Mireia Primé-Tous and Gabrielle A. Carlson
    Citation: Borderline Personality Disorder and Emotion Dysregulation 2024 11:5

Meet the Editor

Back to top

Stefan Röpke, MD, Charité - Universitätsmedizin Berlin, Germany

Stefan Röpke is head of the Trauma Related Disorders Research Group at the Department of Psychiatry at Charité - Universitätsmedizin Berlin. He is also the medical director of the Oberbergklinken Berlin-Brandenburg. He specialises in the treatment of patients with post-traumatic stress disorder (PTSD) and personality disorders, especially borderline personality disorder (BPD). He leads several pharmacological clinical studies on nightmares in PTSD. In addition, his work focuses on exploring the neurobiology of PTSD and BPD using social neuroscience techniques, neurocognitive tasks and brain imaging. Current research topics include affect regulation, social cognition, memory, and basic processes of psychotherapy.

About the Collection

Emotion dysregulation is considered a transdiagnostic symptom and an underlying mechanism of psychopathology. It is present in patients with borderline personality disorder, complex PTSD, and ADHD, among others. While there are evidence-based behavioral interventions to improve emotion dysregulation, pharmacological strategies are less well studied.

This Collection focuses on pharmacologic strategies for modulating emotion regulation. Clinical intervention studies are welcome, as are laboratory studies. We encourage submission of feasibility studies and confirmatory data on pharmacologic interventions that focus on emotion dysregulation, whether transdiagnostic or in specific clinical groups. In addition, research on basal mechanisms of emotion regulation that could serve as the basis for future pharmacological intervention strategies is welcome.

Submission Guidelines

Back to top

This Collection welcomes submission of original research articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Pharmacotherapy of Emotion Dysregulation" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.